MAP2K7 and Hepatic fibrosis: Moreover, in patients with liver cirrhosis and HCC, the overexpression of Raf, MEK, and ERK has also been detected [51], suggesting the overactivation of ERK in hepatic fibrosis, liver cirrhosis, and HCC.